CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Operating Activities
Net (loss) earnings	$ 17,738	$ 7,453
Net (Loss) Earnings from Discontinued Operations	(567)	1,044
Net Earnings from Continuing Operations	18,305	6,409
Impairment & divestiture (benefits) charges	147	0
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	3,426	4,193
Stock-based compensation expense	2,717	2,155
Benefit for deferred income taxes	(24)	(33)
Amortization of debt issuance costs	146	460
Other Noncash Income (Expense)	1,527	11
Changes in components of working capital and other, excluding acquisitions and divestitures:
Accounts receivable	2,517	9,844
Inventories	(4,590)	(5,684)
Trade accounts payable	(4,984)	2,130
Prepaid expenses and other assets	(9,089)	(8,377)
Income tax accounts	1,051	5,104
Accrued compensation and benefits	(11,154)	1,529
Other accrued liabilities	(3,912)	73
Cash provided by (used in) operating activities, Continuing Operations	(3,917)	17,814
Cash (used in) provided by operating activities, Discontinued Operations	(2,758)	(281)
Cash (Used in) Provided By Operating Activities	(6,675)	17,533
Investing Activities
Capital expenditures	(1,567)	(2,535)
Cash used in investing activities, Continuing Operations	(2,594)	(2,535)
Cash Provided by Investing Activities	(2,594)	(2,535)
Financing Activities
Borrowings on Revolving Credit	39,000	14,000
Principal Repayment on Revolving Credit Facility	(8,000)	(11,000)
Principal repayments on term loan	(625)	0
Taxes paid related to the net share settlement of equity awards	(2,081)	(969)
Stock option exercises & other	2,317	972
Cash dividend	(2,178)	(2,274)
Net Cash Used in Financing Activities, Continuing Operations	2,317	(5,688)
Cash used in financing activities	2,317	(5,688)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(6,459)	8,544
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	493	(766)
Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less	0	(4,000)
Payments of Debt Issuance Costs	0	(2,417)
Payments for Repurchase of Common Stock	(26,116)	0
Proceeds from Issuance of Term Loan	0	200,000
Payment for redemption of term loan	0	(200,000)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	147,956	129,243
Purchase of assets	$ (1,027)	$ 0